178 results
S-3ASR
EX-25.1
American Medical Systems Europe B.V.
18 Feb 25
Automatic shelf registration
4:48pm
or bank safety and soundness.
(February 8, 2021)
Exhibit 6
CONSENT
In accordance with Section 321(b) of the Trust Indenture Act of 1939
8-K
EX-99.1
BSX
Boston Scientific Corporation
5 Feb 25
Boston Scientific announces results for
6:41am
at AF Symposium 2025 that achieved the safety and effectiveness endpoints for the treatment of patients with persistent AF with the FARAPULSE™ Pulsed
8-K
EX-99.1
BSX
Boston Scientific Corporation
16 Jan 25
Other Events
4:26pm
compliance, (iii) the quality and safety of the Company’s products, and (iv) the Company’s insurance program. Composition 1. Members. The Committee shall … federal, state, local and foreign governmental authorities, (ii) the safety and quality of the Company’s products and (iii) other material aspects
8-K
EX-99.1
BSX
Boston Scientific Corporation
24 Jul 24
Boston Scientific Announces Results for Second Quarter 2024
6:35am
of the Modular CRM (mCRM™) System5 which met all pre-specified six-month safety and effectiveness endpoints. This is the first modular cardiac rhythm
8-K
EX-3.1
x16vh69mgde3wy lg753
10 May 24
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors
4:20pm
8-K
EX-3.2
jud16b
10 May 24
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors
4:20pm
8-K
EX-99.1
vjgdydw
24 Apr 24
Boston Scientific Announces Results for First Quarter 2024
6:34am
8-K
EX-1.1
rjhsugu1l
27 Feb 24
Entry into a Material Definitive Agreement
4:37pm
8-K
EX-99.1
k9t2gf7oy6h2pa7aob
31 Jan 24
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
6:32am
8-K
EX-2.1
0fsz9ku
8 Jan 24
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-99.2
ziv0 eylw
8 Jan 24
Acquisition to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction
7:06am
8-K
EX-99.1
0p0f5lnk
8 Jan 24
Acquisition to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction
7:06am
8-K
EX-99.1
mg2k4b mnlx36t3
26 Oct 23
Boston Scientific Announces Results for Third Quarter 2023
6:36am